| Particulars |
|
|
|
| Company Name
| Aurobindo Pharma Ltd
| Year End
| 202503
|
| Full Year |
| Equity (₹ Cr.) |
58.59 |
B.V. (₹) |
350.50 |
| Sales(₹ Cr.) |
10,933.30 |
NP (₹ Cr.) |
1,741.31 |
| NP Var (%) |
-11.00 |
Div% |
0.00 |
| CPS(₹) |
34.80 |
EPS (₹) |
29.70 |
| Traded Value(₹ Lakhs) |
173.65 |
52 Week High |
1,501.00 |
| 52 Week Low |
994.00 |
Price BSE |
1,123.00 |
| Price NSE |
1,125.00 |
Market Capital (₹ Cr.) |
65,827.27 |
| P/C Ratio |
32.30 |
P/E Ratio |
37.80 |
| Price Vs.BV |
3.20 |
|
| Latest Quarter |
| Year End |
202506 |
Sales (₹ Cr.) |
2,822.14 |
| NP(₹ Cr.) |
559.13 |
NP Var % |
70.00 |
| Trailing Twelve Months |
| Year End |
202506 |
Sales |
10,713.37 |
| OPM |
23.11 |
NP |
2,069.02 |
| NP Var (%) |
3.44 |
EPS |
33.74 |
| PE |
33.30 |
|
|